EGFR and breast cancer: Other drugs, such as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for lung cancer and cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors for breast cancer demonstrate high efficacy (10, 11), but they are also associated with DIILD (12, 13).